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| BACKG ROU N D

| Preparticipation medical examinations (PPMEs)
Preparticipation medical examinations, otherwise known as periodic health evaluations (PHEs), are encouraged and widely used for health screening in elite athletes. The International Olympic Committee (IOC) published a consensus statement on PHEs for elite athletes in 2009. 1 The main purpose of PPMEs is to screen for injuries and disorders such as cardiovascular abnormalities in athletes, which may limit their ability to safely participate in sporting events. 1 The other purpose is to ensure that current health problems that deteriorate an athlete's performance, such as anemia, are managed appropriately. Ultimately, PPMEs are used to determine whether an athlete is medically capable of engaging in a particular sports event. 1 According to the IOC statement, PPMEs have been introduced worldwide as a standard procedure to detect rare and serious diseases as well as common conditions that may influence an athlete's daily performance. 1 However, there is insufficient evidence to demonstrate the usefulness of PPMEs for monitoring the prevalence of anemia among elite athletes.
| The prevalence of anemia among athletes
Anemia is an important disease in athletes because the hemoglobin (Hb) concentration in the peripheral blood is strongly related to physical performance. 2 Iron deficiency anemia, in particular, causes easy fatigability and decreased performance in athletes. The prevalence of iron deficiency anemia among elite athletes in the United
States is approximately 3%, which is similar to that of untrained individuals. 3 The prevalence of anemia in the general Japanese population was first reported in 1947 in a national survey. 4 However, the diagnosis of anemia at that time was based only on physical examinations such as checking the palpebral conjunctiva and color of the nail. The prevalence of anemia based on a hematological test was reported for the first time in 1972. In people aged 18-24 years, the prevalence of anemia was 15.1% and 25.5% in men and women, respectively. 4 Subsequently, in a national survey of the general Japanese population, the prevalence of anemia was investigated annually. However, there are no available data regarding the trends in the prevalence of anemia among Japanese Universiade athletes using PPMEs, and in this study, we aimed to elucidate these trends using this data.
| MATERIAL S AND ME THODS
| Participants
| Universiade athletes
In this retrospective, observational study, we collected data on
Universiade athletes from official published reports of the Japanese We collected information on the published number of participants and the number of anemic Universiade athletes to calculate the prevalence of anemia. All published data were prepared based on data from
PPMEs. All Universiade athletes were between 18 and 22 years old.
| Nonathletic population
The prevalence of anemia in the nonathletic population (as a control group) was determined based on data from and Welfare in Japan. 4 These surveys were performed every November to understand the health status, nutritional intake, and lifestyle habits among nonathletes and to obtain the basic data necessary to promote comprehensive health in Japan. 4 These annual surveys included between 15 000 and 20 000 household members from the general public from 5000 to 6000 households in 300 unit districts. Survey participants were selected using stratified random sampling from each unit district, as set by In these subjects, blood tests were only performed on par- For that period, we collected data from the 18-to 24-year-old group.
| Preparticipation medical examinations
The Japan Sports Association (JSA) conducted PPMEs between 1956
and 1989. After the Japanese Olympic Committee (JOC) was created by the JSA as an independent organization in 1989, they assumed responsibility for PPME administration. The evaluation components of the PPME are as follows: inquiry (including whether the athlete is being 
| Statistical analysis
In each published report, anemia was defined as an Hb concentration of <14 g/dL for men and <12 g/dL for women. This cutoff has been used routinely in national official reports in Japan. We compared the prevalence of anemia in Universiade athletes (the total number of anemic athletes/total number of athletes × 100) with that of nonathletes (the total number of anemic nonathletes/total number of nonathletes × 100) using an unpaired t test. All statistical tests were two-tailed. The statistical analyses were conducted using SPSS statistics version 23® (IBM, New
York, NY, USA). P-values <.05 were considered statistically significant.
| Ethical considerations
All Universiade athletes were educated regarding the necessity of PPMEs and provided informed consent for the utilization of all results for official published reports before the PPME was initiated. Likewise, nonathletic participants were also informed of the necessity of The 
| RE SULTS
| Participants
We investigated 18 official published reports of the Japanese delega- 
| Comparison of the prevalence of anemia
| D ISCUSS I ON
| The prevalence of anemia
This study clearly demonstrates that there was a higher prevalence of anemia in female Universiade athletes than in the nonathletic female population in 1977. However, this study also demonstrates that the prevalence of anemia in the total Universiade athlete population significantly improved over long-term observation. Because the prevalence remained somewhat constant for male athletes, the reduction in prevalence may be largely due to the decrease in prevalence among female athletes. Because no study has evaluated the prevalence of anemia in Universiade athletes, this study is the first report that revealed longitudinal changes in the prevalence of anemia in Universiade athletes.
Anemia in athletes has multiple causes. The most common form of anemia that is observed in elite athletes is dilutional pseudoanemia secondary to expansion of the plasma volume, 21 which does not result in any deterioration in physical performance. Iron deficiency anemia, which causes easy fatigability and decreased physical performance, is another common and important type of anemia in elite athletes. 21 As iron is lost in both sweat 22 and gastrointestinal bleeding, and hemolysis is a common occurrence during stress and repeated injuries to the foot, 23, 24 athletes are frequently anemic. Additionally, female athletes have a high risk of iron depletion and iron deficiency anemia because of menstruation. [25] [26] [27] At the annual health examination for elite Japanese athletes in 1987, the prevalence of anemia was reported as 7.5% and 21.5% in male and female subjects, respectively. 28 Compared with the low prevalence of iron deficiency anemia (approximately 3%) among elite athletes in the United States, 3 the prevalence of anemia in Japan at that time was surprisingly high. However, since then, advanced knowledge in sports medicine, particularly exercise physiology and sports hematology, has become widespread, leading to a subsequent decrease in the prevalence of iron deficiency anemia in elite athletes (4.7% and 5.4% in male and female subjects, respectively, in 1999). 
| PPMEs for Universiade athletes
Only one large-scale PPMEs study required a hematological test for college athletes. 30 In 
| Limitations
This study has some limitations. First, there are multiple missing data in this study. Though we used the data described in the official published reports of the Japanese delegation for the summer Universiade games and the national surveys of the corresponding year for each competition, it was impossible to obtain all the data as there were different formats for the descriptions of the number and prevalence of anemia in each report. Indeed, in case in which there was missing value, it was difficult to determine the progress and the factors involved in the change. However, the fact that these longitudinal PPMEs revealed improvement in the prevalence of anemia in Universiade athletes in contrast to nonathletes F I G U R E 4 Scatter plot comparing the prevalence of anemia in female Universiade athletes and nonathletes by year. UA: Universiade athletes. Control: nonathletic population was an important result with regard to the improvement of total support to Japanese athletes. It was also difficult to determine additional details regarding the condition of anemic athletes, including the number of athletes under treatment, the type of anemia, or their athletic performances under anemic conditions as this was retrospective study utilizing published data from official reports.
Moreover, there were no other relevant hematological parameters that could be studied, including mean corpuscular volume, mean corpuscular Hb, serum iron value, total iron-binding capacity, and serum ferritin level. Therefore, further investigations are necessary.
| CON CLUS ION
In this study, improvement in the prevalence of anemia in Japanese
Universiade athletes was revealed using longitudinal PPMEs. We should evaluate hematological parameters in athletes longitudinally, make appropriate diagnoses, and provide continuous support to improve their performance throughout their career.
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